Potential Anti-SARS-CoV-2 Molecular Strategies

Herein we describe some molecular aspects of the recent anti-COVID-19 research, including some approaches making use of natural remedies, especially from medicinal plants, in silico methods, and different experimental procedures that led to the discovery of novel targets of SARS-CoV-2 and consequent...

Full description

Saved in:
Bibliographic Details
Other Authors: Roviello, Giovanni N. (Editor), Vicidomini, Caterina (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_98898
005 20230405
003 oapen
006 m o d
007 cr|mn|---annan
008 20230405s2023 xx |||||o ||| 0|eng d
020 |a books978-3-0365-6962-8 
020 |a 9783036569635 
020 |a 9783036569628 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-6962-8  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a TB  |2 bicssc 
072 7 |a TCB  |2 bicssc 
100 1 |a Roviello, Giovanni N.  |4 edt 
700 1 |a Vicidomini, Caterina  |4 edt 
700 1 |a Roviello, Giovanni N.  |4 oth 
700 1 |a Vicidomini, Caterina  |4 oth 
245 1 0 |a Potential Anti-SARS-CoV-2 Molecular Strategies 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2023 
300 |a 1 electronic resource (254 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Herein we describe some molecular aspects of the recent anti-COVID-19 research, including some approaches making use of natural remedies, especially from medicinal plants, in silico methods, and different experimental procedures that led to the discovery of novel targets of SARS-CoV-2 and consequently novel potential COVID-19 therapeutics. COVID-19 vaccines also find mention in this book with also a description of some adverse effects reported in some cases. Considering that the different beta coronaviruses present certain conserved biomolecular mechanisms and, thus, some common therapeutic targets, finding effective therapies for a specific member of their family (such as SARS-CoV, SARS-CoV-2, and MERS-CoV) even in a scenario of a reduced impact at the time of the related disease on humankind is still relevant as it could offer or inspire efficacious therapeutic strategies not only in the context of novel pathogenic mutations of the already known beta coronaviruses, but also when future zoonoses caused by other beta coronaviruses will emergence, which is not unlikely to occur in the current world where the interactions between humans and wildlife are made more and more frequent due to the growing loss of intact ecosystems worldwide. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Technology: general issues  |2 bicssc 
650 7 |a Biotechnology  |2 bicssc 
653 |a coronavirus infections 
653 |a pandemics 
653 |a natural compounds 
653 |a clove 
653 |a Syzygium aromaticum 
653 |a eugenol 
653 |a eugeniin 
653 |a SARS-CoV-2 
653 |a COVID-19 
653 |a phytochemicals 
653 |a herbal medicine 
653 |a catechin 
653 |a polyphenol 
653 |a tea leaf extract 
653 |a theaflavin 
653 |a virucidal activity 
653 |a MERS-CoV 
653 |a S1-NTD 
653 |a pharmacophore modeling 
653 |a ADME 
653 |a quantum mechanical calculation 
653 |a DFT 
653 |a FMO 
653 |a MM/GBSA 
653 |a molecular docking 
653 |a Molecular Dynamics Simulation 
653 |a HOMO 
653 |a LUMO 
653 |a COVID-19 vaccine 
653 |a disseminated intravascular coagulation 
653 |a heparin induced thrombocytopenia 
653 |a platelet factor 4 
653 |a thrombosis 
653 |a thrombotic thrombo-cytopenic purpura 
653 |a vaccine induced thrombocytopenia and thrombosis 
653 |a disinfectants 
653 |a ethanol 
653 |a hand hygiene 
653 |a ozonated water 
653 |a slightly acidic electrolyzed water 
653 |a virucidal mechanism 
653 |a coronavirus 
653 |a renal disease 
653 |a nephrotoxicity 
653 |a reno-protective effect 
653 |a green tea 
653 |a epigallocatechin-3-gallate (EGCG) 
653 |a flavonoids 
653 |a natural products 
653 |a medicinal plant 
653 |a SARS-Cov-2 nsp10 
653 |a structural similarity 
653 |a fingerprint 
653 |a ADMET 
653 |a toxicity 
653 |a main protease 
653 |a triazole 
653 |a docking 
653 |a MD simulation 
653 |a drug 
653 |a proteomic 
653 |a vaccine 
653 |a immunology 
653 |a biomarker 
653 |a cheminformatics 
653 |a phytocompounds 
653 |a systems pharmacology 
653 |a anti-COVID-19 
653 |a drug repositioning 
653 |a molecular dynamic simulations 
653 |a binding free energy 
653 |a signal peptide 
653 |a RBD protein 
653 |a secretion 
653 |a mutant 
653 |a nucleocapsid or nucleoprotein 
653 |a structure-based drug discovery 
653 |a alphafold model and molecular dynamics 
653 |a neuroinflammation 
653 |a brain fog 
653 |a neuropeptides 
653 |a neurotransmission 
653 |a metabolism 
653 |a NSAIDs 
653 |a inflammation 
653 |a ketoprofen 
653 |a n/a 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/6951  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/98898  |7 0  |z DOAB: description of the publication